rs59422275

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_020964.3(EPG5):​c.544A>G​(p.Lys182Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0857 in 1,614,110 control chromosomes in the GnomAD database, including 7,085 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. K182K) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.12 ( 1362 hom., cov: 33)
Exomes 𝑓: 0.083 ( 5723 hom. )

Consequence

EPG5
NM_020964.3 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 1.10

Publications

13 publications found
Variant links:
Genes affected
EPG5 (HGNC:29331): (ectopic P-granules 5 autophagy tethering factor) This gene encodes a large coiled coil domain-containing protein that functions in autophagy during starvation conditions. Mutations in this gene cause Vici syndrome. [provided by RefSeq, Aug 2015]
EPG5 Gene-Disease associations (from GenCC):
  • Vici syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0038298368).
BP6
Variant 18-45954858-T-C is Benign according to our data. Variant chr18-45954858-T-C is described in ClinVar as Benign. ClinVar VariationId is 402834.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.215 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EPG5NM_020964.3 linkc.544A>G p.Lys182Glu missense_variant Exon 2 of 44 ENST00000282041.11 NP_066015.2 Q9HCE0-1Q9BTI0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EPG5ENST00000282041.11 linkc.544A>G p.Lys182Glu missense_variant Exon 2 of 44 1 NM_020964.3 ENSP00000282041.4 Q9HCE0-1

Frequencies

GnomAD3 genomes
AF:
0.116
AC:
17605
AN:
152180
Hom.:
1358
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.219
Gnomad AMI
AF:
0.0603
Gnomad AMR
AF:
0.0778
Gnomad ASJ
AF:
0.123
Gnomad EAS
AF:
0.0239
Gnomad SAS
AF:
0.0766
Gnomad FIN
AF:
0.0439
Gnomad MID
AF:
0.117
Gnomad NFE
AF:
0.0835
Gnomad OTH
AF:
0.0989
GnomAD2 exomes
AF:
0.0845
AC:
21063
AN:
249294
AF XY:
0.0833
show subpopulations
Gnomad AFR exome
AF:
0.219
Gnomad AMR exome
AF:
0.0778
Gnomad ASJ exome
AF:
0.125
Gnomad EAS exome
AF:
0.0233
Gnomad FIN exome
AF:
0.0490
Gnomad NFE exome
AF:
0.0802
Gnomad OTH exome
AF:
0.0848
GnomAD4 exome
AF:
0.0826
AC:
120703
AN:
1461812
Hom.:
5723
Cov.:
32
AF XY:
0.0825
AC XY:
59982
AN XY:
727210
show subpopulations
African (AFR)
AF:
0.219
AC:
7341
AN:
33468
American (AMR)
AF:
0.0780
AC:
3486
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.125
AC:
3255
AN:
26136
East Asian (EAS)
AF:
0.0207
AC:
822
AN:
39698
South Asian (SAS)
AF:
0.0859
AC:
7412
AN:
86246
European-Finnish (FIN)
AF:
0.0487
AC:
2599
AN:
53420
Middle Eastern (MID)
AF:
0.104
AC:
600
AN:
5766
European-Non Finnish (NFE)
AF:
0.0809
AC:
89913
AN:
1111972
Other (OTH)
AF:
0.0874
AC:
5275
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
6618
13235
19853
26470
33088
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3348
6696
10044
13392
16740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.116
AC:
17618
AN:
152298
Hom.:
1362
Cov.:
33
AF XY:
0.112
AC XY:
8319
AN XY:
74458
show subpopulations
African (AFR)
AF:
0.218
AC:
9075
AN:
41548
American (AMR)
AF:
0.0777
AC:
1189
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.123
AC:
425
AN:
3466
East Asian (EAS)
AF:
0.0236
AC:
122
AN:
5178
South Asian (SAS)
AF:
0.0766
AC:
370
AN:
4828
European-Finnish (FIN)
AF:
0.0439
AC:
466
AN:
10620
Middle Eastern (MID)
AF:
0.109
AC:
32
AN:
294
European-Non Finnish (NFE)
AF:
0.0835
AC:
5678
AN:
68028
Other (OTH)
AF:
0.0974
AC:
206
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
797
1593
2390
3186
3983
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
190
380
570
760
950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0929
Hom.:
2614
Bravo
AF:
0.123
TwinsUK
AF:
0.0736
AC:
273
ALSPAC
AF:
0.0734
AC:
283
ESP6500AA
AF:
0.203
AC:
784
ESP6500EA
AF:
0.0832
AC:
687
ExAC
AF:
0.0872
AC:
10530
Asia WGS
AF:
0.0610
AC:
210
AN:
3478
EpiCase
AF:
0.0840
EpiControl
AF:
0.0848

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 24, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not specified Benign:1
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: MAF -

Vici syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.070
BayesDel_addAF
Benign
-0.79
T
BayesDel_noAF
Benign
-0.76
CADD
Benign
7.5
DANN
Benign
0.92
DEOGEN2
Benign
0.0035
T;T
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.13
N
LIST_S2
Benign
0.37
.;T
MetaRNN
Benign
0.0038
T;T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
0.20
N;N
PhyloP100
1.1
PrimateAI
Benign
0.21
T
PROVEAN
Benign
-0.24
N;.
REVEL
Benign
0.039
Sift
Benign
0.51
T;.
Sift4G
Benign
0.54
T;.
Polyphen
0.0010
B;B
Vest4
0.065
MPC
0.21
ClinPred
0.0032
T
GERP RS
2.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.053
gMVP
0.19
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs59422275; hg19: chr18-43534824; COSMIC: COSV56346706; API